The Medical Device Authority (MDA) of Malaysia has issued an official announcement confirming the introduction of an Automated Re-Registration Route within the upgraded MeDC@St 2.0+ platform. According to the announcement, the new route will be implemented starting July 13, 2026.
From this date onward, medical device re-registration applications submitted to MDA may — if they meet the applicable conditions — be processed through this optimized automated workflow. Applications submitted before July 13, 2026 will continue to be handled under the normal evaluation route.
Key Facts of the Announcement
| Item | Detail |
|---|
| Regulatory Authority | Medical Device Authority (MDA), Malaysia |
| Platform | MeDC@St 2.0+ |
| New Pathway | Automated Re-Registration Route |
| Effective Date | July 13, 2026 |
| Applicable Submissions | Re-registration applications submitted on or after the effective date that meet the eligibility conditions |
| Earlier Submissions | Applications submitted before the effective date are processed under the normal evaluation route |
What This Means for Medical Device and IVD Suppliers
Malaysia is a key market for medical device manufacturers and distributors in Southeast Asia, including suppliers of in-vitro diagnostic (IVD) products such as ELISA reagent kits. For registration holders whose product registrations are approaching expiry, the introduction of the automated re-registration route is expected to bring a more efficient renewal experience — provided that all conditions are satisfied.
- Eligible re-registration applications submitted from July 13, 2026 can enter the streamlined automated workflow instead of the standard manual evaluation path.
- Applications already submitted before the effective date will not be transferred to the new route and must follow the ordinary assessment process.
- Eligibility depends on the submission conditions; companies should review the MDA announcement and confirm that their product dossiers remain complete and compliant.
- IVD and ELISA reagent suppliers should align their renewal schedules with the new implementation date to make full use of the faster pathway.
Recommended Actions for Registration Holders
- Check the current registration and expiry status of your medical devices, including IVD ELISA reagent kits, in MeDC@St.
- Confirm whether your upcoming re-registration meets the conditions for the Automated Re-Registration Route.
- Prepare complete and up-to-date technical documentation well in advance of submission.
- For renewals that qualify, plan to submit on or after July 13, 2026 to benefit from the automated process.
- Consult MDA official channels or your local authorized representative for case-specific guidance.
About MDA and MeDC@St
The Medical Device Authority (MDA) is Malaysia's national regulatory body responsible for the regulation of medical devices. MeDC@St is the authority's centralized online system through which medical device registration and related regulatory transactions are conducted. The upgraded MeDC@St 2.0+ platform continues to digitalize regulatory workflows, and the new Automated Re-Registration Route represents another step toward a faster and more transparent renewal environment for the medical device industry.
Suppliers of IVD ELISA reagents and other medical devices exporting to Malaysia are advised to monitor MDA announcements closely and prepare their renewal strategies ahead of the July 13, 2026 implementation date.
¡Su mensaje debe tener entre 20 y 3.000 caracteres!
Spanish
